Stahl A - Search Results

1

Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.

Stahl A, Bründer MC, Lagrèze WA, Molnár FE, Barth T, Eter N, Guthoff R, Krohne TU, Pfeil JM; CARE-ROP Study Group. Stahl A, et al. Acta Ophthalmol. 2022 Feb;100(1):e91-e99. doi: 10.1111/aos.14852. Epub 2021 Mar 19. Acta Ophthalmol. 2022. PMID: 33742551 Free PMC article. Clinical Trial.

2

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro.

Stahl A, Paschek L, Martin G, Gross NJ, Feltgen N, Hansen LL, Agostini HT. Stahl A, et al. FEBS Lett. 2008 Sep 3;582(20):3097-102. doi: 10.1016/j.febslet.2008.08.005. Epub 2008 Aug 12. FEBS Lett. 2008. PMID: 18703055 Free article.

3

Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Stahl A, Krohne TU, Sapieha P, Chen J, Hellstrom A, Chew E, Holz FG, Smith LE. Stahl A, et al. Br J Ophthalmol. 2011 Nov;95(11):1496-501. doi: 10.1136/bjo.2010.194241. Epub 2011 Mar 18. Br J Ophthalmol. 2011. PMID: 21421650 Free PMC article. Review.

4

[Pharmacological treatment for retinopathy of prematurity].

Stahl A, Agostini H, Jandeck C, Lagrèze W. Stahl A, et al. Ophthalmologe. 2011 Aug;108(8):777-85; quiz 786-7. doi: 10.1007/s00347-011-2371-4. Ophthalmologe. 2011. PMID: 21853221 German.

5

Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

Chen J, Joyal JS, Hatton CJ, Juan AM, Pei DT, Hurst CG, Xu D, Stahl A, Hellstrom A, Smith LE. Chen J, et al. Among authors: stahl a. Invest Ophthalmol Vis Sci. 2012 May 17;53(6):2968-77. doi: 10.1167/iovs.12-9691. Invest Ophthalmol Vis Sci. 2012. PMID: 22491401 Free PMC article.

6

[Retinopathy of prematurity].

Jandeck C, Stahl A. Jandeck C, et al. Among authors: stahl a. Klin Monbl Augenheilkd. 2012 May;229(5):559-75; quiz 576-7. doi: 10.1055/s-0031-1298437. Epub 2012 May 16. Klin Monbl Augenheilkd. 2012. PMID: 22592347 German. No abstract available.

7

[Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].

Stahl A, Aisenbrey S, Krohne TU. Stahl A, et al. Klin Monbl Augenheilkd. 2012 Oct;229(10):1024-9. doi: 10.1055/s-0032-1315247. Epub 2012 Sep 7. Klin Monbl Augenheilkd. 2012. PMID: 22961043 Review. German.

8

[Pathogenesis of retinopathy of prematurity].

Stahl A, Lagrèze WA, Agostini HT. Stahl A, et al. Ophthalmologe. 2012 Dec;109(12):1174-81. doi: 10.1007/s00347-012-2616-x. Ophthalmologe. 2012. PMID: 23212354 German.

9

Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?

Stahl A, Hellstrom A, Smith LE. Stahl A, et al. Neonatology. 2014;106(3):254-60. doi: 10.1159/000365132. Epub 2014 Oct 5. Neonatology. 2014. PMID: 25300950 Free PMC article. Review.

10

Screening and Treatment in Retinopathy of Prematurity.

Stahl A, Göpel W. Stahl A, et al. Dtsch Arztebl Int. 2015 Oct 23;112(43):730-5. doi: 10.3238/arztebl.2015.0730. Dtsch Arztebl Int. 2015. PMID: 26568177 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,262 results

Search Page

Filters